2011
DOI: 10.3109/07853890.2011.605389
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and treatment of mitochondrial myopathies

Abstract: Mitochondrial disorders are a heterogeneous group of disorders resulting from primary dysfunction of the respiratory chain. Muscle tissue is highly metabolically active, and therefore myopathy is a common element of the clinical presentation of these disorders, although this may be overshadowed by central neurological features. This review is aimed at a general medical and neurologist readership and provides a clinical approach to the recognition, investigation, and treatment of mitochondrial myopathies. Empha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
113
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 129 publications
(118 citation statements)
references
References 98 publications
3
113
0
2
Order By: Relevance
“…Symptoms often involve the central nervous and cardiovascular systems. Kearns-Sayre syndrome, for example, is defined by the classical triad of age of onset before 20, extraocular muscle weakness, and pigmentary retinopathy, plus one of the following: ataxia, protein level greater than 100 mg/dL in cerebrospinal fluid, or cardiac conduction abnormalities [10]. Mitochondrial disease can be investigated either molecularly by gene panel or whole-exome sequencing, or by pathologic findings on muscle biopsy of abnormal respiratory chain function or the presence of ragged red fibers.…”
Section: Discussionmentioning
confidence: 99%
“…Symptoms often involve the central nervous and cardiovascular systems. Kearns-Sayre syndrome, for example, is defined by the classical triad of age of onset before 20, extraocular muscle weakness, and pigmentary retinopathy, plus one of the following: ataxia, protein level greater than 100 mg/dL in cerebrospinal fluid, or cardiac conduction abnormalities [10]. Mitochondrial disease can be investigated either molecularly by gene panel or whole-exome sequencing, or by pathologic findings on muscle biopsy of abnormal respiratory chain function or the presence of ragged red fibers.…”
Section: Discussionmentioning
confidence: 99%
“…Dysfunction is most likely to occur in tissues/ organs with high energy requirements, therefore explaining that MM most often affects muscles (particularly extraocular muscle), and the nervous, cardiac, and endocrine systems. A detailed description of all mitochondrial myopathies, and their clinical characteristics, prognosis, diagnosis, and treatment is beyond the scope of this review, although this topic was recently reviewed in detail [26]. Clinically apparent respiratory dysfunction in mitochondrial myopathies appears to be an unusual finding: in recent series, respiratory dysfunction has similar prevalence to controls in patients with the m.3243A[G mutation [27], and was present in only one of 40 patients in a recent PEO series [28].…”
Section: Metabolic Myopathiesmentioning
confidence: 99%
“…Inborn OXPHOS complex deficiencies caused by mutations in mitochondrial or nuclear DNA (mtDNA and nDNA, respectively), can lead to various diseases, concerning mostly tissues with high relative energy demand (in relation to OXPHOS capacity), such as skeletal muscle or neural tissue [40,5,13,35,36,39,34]. They are characterized by a threshold value of an OXPHOS complex/whole OXPHOS activity below which the disease develops.…”
Section: Introductionmentioning
confidence: 99%